SCHEMBL10484153

SCHEMBL10484153

Oc1ccc(/C(=C(/c2ccccc2)C(F)(F)F)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.56
CYP19A1 P11511 4/20 0.47
ESR2 Q92731 4/20 0.47
CES2 O00748 1/20 0.47
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
CES1 P23141 1/20 0.42
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
GLA P06280 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA9 Q16790 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA14 Q9ULX7 1/20 0.39
ESRRB O95718 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10483997 1.00 ESR1 (0.56) ESR1CYP19A1ESR2CES2MEN1
SCHEMBL10483990 1.00 ESR1 (0.56) ESR1CYP19A1ESR2CES2MEN1
SCHEMBL9056053 0.89 CES1 (0.50) ESR1CES2MAPTRAB9ACES1
SCHEMBL10484201 0.87 CES2 (0.47) ESR1CYP19A1ESR2CES2LMNA
SCHEMBL10484187 0.87 CES2 (0.47) ESR1CYP19A1ESR2CES2LMNA
SCHEMBL10484473 0.84 CES1 (0.42) ESR1CES2MEN1KMT2ALMNA
SCHEMBL10484481 0.84 CES1 (0.42) ESR1CES2MEN1KMT2ALMNA
SCHEMBL11711262 0.82 CYP19A1 (0.41) ESR1CYP19A1ESR2MEN1KMT2A
SCHEMBL11711270 0.82 CYP19A1 (0.41) ESR1CYP19A1ESR2MEN1KMT2A
SCHEMBL1151837 0.78 ESR1 (0.70) ESR1ESR2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4806685-A EXERTS VARIOUS EFFECTS ON ENDOCRINOUS SYSTEM OF RATS; INHIBITS GROWTH OF MAMMARY TUMORS GYOGYSZERKUTATO INTEEZET/PHARMACEUTICAL RESEARCH INSTITUTE (HU) 1989-02-21 US disclosed